Ethically Indefensible: Neuropathic Pain, Medical Cannabis & Organ Transplant Eligibility is a supplement to Stigma with a Body Count: Medical Cannabis & Organ Transplant Policies, a March 2026 report that documents how discrimination and bias distort access to life-saving care for patients who use cannabis medicines.
Designed specifically for members of transplantation programs, committees, and teams who evaluate patients and help shape organ-transplant eligibility policies, this primer aims to improve their understanding of severe neuropathic pain and its prevalence in organ-related diseases, explain why medical cannabis may be an important part of a candidate’s treatment plan, and outline the clinical management issues relevant to transplant care.
ASA offers this primer in the hope that transplant professionals will support cannabis policies grounded in clinical evidence rather than stigma.
Additional Resources:
Stigma with a Body Count: Medical Cannabis & Organ Transplant Policies
For more information on organ transplants & Americans for Safe Access, visit:
Share this page
